← Open Payments lookup

VINU GANTI: Open Payments

NPI 1760499826 · GERMANTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,996 in 98 payments from 20 companies in 2025. Trend: 2023 $3,033 · 2024 $2,406 · 2025 $1,996

Food & beverage: $1,876Education: $120
CompanyPaymentsAmount
Novo Nordisk Inc18$263
AstraZeneca Pharmaceuticals LP12$253
Bayer Healthcare Pharmaceuticals Inc.9$218
ABBVIE INC.14$215
Lilly USA, LLC8$168
GlaxoSmithKline, LLC.7$154
Actelion Pharmaceuticals US, Inc.1$100
Amgen Inc.5$93
Merck Sharp & Dohme LLC4$83
Vanda Pharmaceuticals Inc.3$70

Products named: Kerendia, BREZTRI, TRELEGY ELLIPTA, QULIPTA, OPSUMIT, VRAYLAR, Ozempic, KISUNLA.

Industry payments across MD — which companies pay providers there.